Tilray Inc. (TLRY)

Analyst

Current Average Recommendation 2.47 Moderate Buy Previous Recommendation (1 Month Ago) 2.47 Change in Average Recommendation 0 Number of Analysts Reporting 15 Strong Sell Moderate Hold Moderate Strong Buy Sell Buy

Strong Buy 4 Moderate Buy 0 Hold 11 Moderate Sell 0 Strong Sell 0

Industry MED-DRUGS TLRY is ranked 189th / Number of companies in industry 221 221 in MED-DRUGS Rank Recommendation 189

Company Profile

Exchange: Tilray is a Canadian producer that cultivates and sells medical and NGS recreational . In 2021, legacy Aphria acquired legacy Tilray in a Company Address: reverse merger and renamed itself Tilray. The bulk of its sales are in and in the international export market. U.S. 655 Madison Avenue, Suite 1900 exposure consists of CBD products through Manitoba Harvest and beer New York, NY, US, 10065 through SweetWater. Contact: Website https://www.tilray.com Phone +1 844 845-7291 Fax Email mgalloro@aloefinancial.com Sector: Industry: SIC: Healthcare Drug Manufacturers

CEO: Employees: Auditor: Irwin D. Simon 2100 PricewaterhouseCoopers LLP Stock Performance

11.00 ▾ 10/01/2021 06:05pm -0.29 | -2.57% Share Volume: 14.09m Trade Volume: 57.13k

Bid (size): 11.00 (5,100) Ask (size): 11.01 (5,600)

Open: 11.29 Prev Close: 11.29

High 11.37 52wk High: 67.00

Low: 10.84 52wk Low: 4.71

VWAP: 11.024 Beta: 0.00

Market Cap: 4.91b Shares Out: 446.16m

EPS: -2.32 Dividend: N/A

P/E Ratio: 0.00 P/B Ratio: 5.288

Recent News & Filings

10/01/2021 03:00pm Cannabis Selloff: 3 Weed Stocks to Avoid and 1 Must-Buy - Motley Fool Canada 09/30/2021 09:50pm Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know - Zacks 09/30/2021 05:00pm Buzz stocks trail the broad market in September but quant analysis plays - SeekingAlpha 09/30/2021 01:00pm Rising Natural Wellness Momentum Fuels Cannabis Market - InvestorBrandNetwork 09/30/2021 12:00pm 3 Cannabis Stocks to Buy Before the Next Boom - Motley Fool Canada 09/29/2021 04:01pm Trulieve Cannabis: Florida Market About To Over Heat - SeekingAlpha 09/29/2021 02:00pm Best Canadian Marijuana Stocks To Buy? 2 For Your List In October 2021 - MarijuanaStocks.com 09/28/2021 01:00pm , Not US, Spearheading Advancements in Global Cannabis Markets - InvestorBrandNetwork 09/27/2021 06:24pm Outperforming cannabis mutual fund converts to an ETF - SeekingAlpha 09/27/2021 05:16pm Why Sundial, Tilray, Canopy Growth, and Stocks Are Glowing Green Today - Motley Fool

Corporate Events

Date/Time Event Details 2021-10-27 Earnings Event for Q3 2021. (More) 2021-10-07 Earnings Event for Q1 2022. (More) 2021-07-28 Earnings Event for Q2 2021, EPS of 0.18 (More) 2021-07-28 Earnings Event for Q4 2021. (More) 2021-05-10 Earnings Event for Q1 2021, EPS of -2.01 (More) 2021-05-01 Negative Surprise of -37.5%. Expected EPS of -0.08; and Actual EPS of -0.11. 2021-03-01 Negative Surprise of -90%. Expected EPS of -0.1; and Actual EPS of -0.19. 2021-02-17 Earnings Event for Q4 2020, EPS of -0.02 (More) 2021-02-01 N/A of undefined%. Expected EPS of undefined; and Actual EPS of undefined. 2020-12-01 Positive Surprise of 42.86%. Expected EPS of -0.14; and Actual EPS of -0.08. 2020-11-09 Earnings Event for Q3 2020, EPS of -0.02 (More) 2020-11-09 Cantor Fitzgera announces Initiated from undefined to Neutral. 2020-09-01 Negative Surprise of -28.57%. Expected EPS of -0.21; and Actual EPS of -0.27. 2020-08-10 Earnings Event for Q2 2020, EPS of -0.65 (More) 2020-06-01 Positive Surprise of 3.7%. Expected EPS of -0.27; and Actual EPS of -0.26. Share Information

Price Comparison Volume Comparison

Latest Fiscal Date: 2021-05-31 Latest Fiscal Revenue: 541.09m Short Interest: -- () Short Interest Ratio: -- Float: 165.40m % of Float: 37.07% Institute Holdings: 24.40% (2021-04-30) Institute Bought / Sold (Prev 3 mo): 5.58m / 2.69m Institute Total Held: 41.90m Total Institutions: 328 Non-Corp. Insider Holdings: 6.20% (2021-03-31) Insider Bought / Sold (Prev 3 mo): 435.38k / 1.40m

Key Ratios

Income Statement Revenue (LTM) ($): 368.40m Revenue per Share (LTM) ($): 0.83 Revenue Growth 3 Yr: 132.07% Revenue Growth 5 Yr: 148.93% Financial Strength (LTM) Quick Ratio: 1.50 Current Ratio: 2.20 Long Term Debt to Total Capital: 0.17 Total Debt to Equity: 0.21 Interest Coverage: -10.20 Leverage Ratio: 1.40 Profitability (LTM) Gross Margin: 24.00 % EBIT Margin: -61.20 % EBITDA Margin: -48.00 % Pre-Tax Profit Margin: 10.10 % Profit Margin (Cont. Op): -90.67 % Profit Margin (Total Op): -90.67 % Management Effectiveness Return on Equity (LTM): -5.82 % Return on Capital (LTM): -0.10 % Return on Assets (LTM): -2.02 % Assets Asset Turnover: 0.10 Inventory Turnover: 1.40 Receivable Turnover: 3.80 Valuation Measures P/E Ratio: -7.90 Price to Sales: 13.67 P/E High - Last 5 Years: -- Price to Book: 8.80 P/E Low - Last 5 Years: -- Price to Tangible Book: 160.15 Price to Free Cash: -31.20 Price to Cash Flow: -- Financial Summary

Currency: USD Last Quarter Fiscal Year Ending 2021-05-31 2021-05-31 --

Income Statement

Revenue 152.19m 513.09m -- -- EBITDA 82.05m (246.25m) -- -- Margin (%) 53.91 % (47.99) % -- -- EBIT 57.24m (314.08m) -- -- Margin (%) 37.61 % (61.21) % -- -- Net Income 14.53m (367.42m) -- -- Margin (%) 9.54 % (71.61) % -- -- Diluted EPS 0.18 (1.25) -- --

Cash Flow Statement

Cash from Operations 6.12m (44.72m) -- -- Cash from Investing 341.05m 46.11m -- -- Cash from Financing (57.15m) 124.31m -- -- Change in Cash 290.03m 125.70m -- --

Balance Sheet

Total Assets 6.03b 6.03b -- -- Total Liabilities 1.56b 1.56b -- -- Total Equity 4.47b 4.47b -- -- Analyst History

Rating Current 1 Month Ago 2 Months Ago 3 Months Ago Strong Buy 4 4 4 4 Moderate Buy 0 0 0 0 Hold 11 11 12 11 Moderate Sell 0 0 0 0 Strong Sell 0 0 0 0 Mean Rec. 2.47 2.47 2.5 2.47

Market data by QuoteMedia. All rights reserved.